Interim Chief Executive Officer and President
Vice President of Finance and Chief Accounting Officer
Kevin has been Vice President of Finance and Chief Accounting Officer since 2014. Previously, he was Vice President, Finance and Administration for Avaxia Biologics, a clinical-stage biopharmaceutical company developing gut-targeted therapeutics. Prior to joining Avaxia, he served from 2009 to 2013 at various biotechnology and medical device companies in interim Vice President of Finance and Controller roles. From 2005 to 2009, Kevin was the Corporate Controller and Principal Accounting Officer of NitroMed, a publicly traded cardiovascular-focused pharmaceutical company. Kevin earned a B.S. in business management from the University of Hartford, an M.B.A. from Boston University and an M.A. in accounting from Suffolk University. He is a certified public accountant in the Commonwealth of Massachusetts.
Matt has served as Enumeral’s General Counsel since 2014, where he is responsible for the legal affairs of the company. Prior to Enumeral, Matt served as General Counsel at Stream Global Services, a multinational business process outsourcing company. Previously, he led the legal functions at several life sciences companies in Massachusetts, including as Deputy General Counsel, Secretary and Treasurer at NitroMed, a publicly-traded cardiovascular-focused pharmaceutical company. Matt began his legal career at Hale and Dorr LLP (now WilmerHale LLP). Matt holds a J.D. from Boston College Law School, an M.B.A. from the Carroll Graduate School of Management at Boston College, and an A.B. from Georgetown University.